Comments
Loading...

TransCode Therapeutics Stock Guidance

RNAZNASDAQ
Logo brought to you by Benzinga Data
$8.16
0.516.67%
At close: -
$7.90
-0.26-3.19%
After Hours: 6:21 PM EDT
TransCode Therapeutics Inc is expected to split Thursday, May 15, 2025 with a ratio of 1:28
Q1 2025 Earnings were released on Wed May 14th, before the market open

TransCode Therapeutics Stock Guidance | NASDAQ:RNAZ | Benzinga

TransCode Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
TransCode Therapeutics Inc (RNAZ) does not provide guidance data

FAQ

Q

What is the most recent guidance for TransCode Therapeutics (RNAZ)?

A

There have been no specific sales or earnings guidance reported for TransCode Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch